The Story of Wall Shear Stress in Coronary Artery Atherosclerosis: Biochemical Transport and Mechanotransduction

coronary artery atherosclerosis is, multifactorial, complex disease locally, and a major cause of death in the United States. complex interaction between transport biochemical and biomechanical forces affecting the growth of the disease.

Wall shear stress (WSS) influence coronary artery atherosclerosis by inducing endothelial cell mechanotransduction and by controlling the near-wall transport processes involved in atherosclerosis. Each process is controlled by a different WSS and because it has complicated the interpretation of WSS in atherosclerosis. In this paper, we present a comprehensive theory for WSS in atherosclerosis.

First, a brief review of mechanotransduction shear stress-mediated atherosclerosis is presented. Next, a special subject of computational fluid dynamics (CFD) simulations performed on ten models of coronary artery diseased subjects and healthy. Specific biochemical mass transportation models developed for the study of low-density lipoprotein, nitric oxide, adenosine triphosphate, oxygen, monocyte chemoattractant protein-1, and transportation monocytes.

Results of transport compared to vector WSS and WSS Lagrangian coherent structures (WSS LCS). WSS high magnitude protected against atherosclerosis by increasing production or biochemical flux atheroprotective and reduce localization near-wall biochemistry atherogenic.

The amount of lower WSS promoted atherosclerosis by increasing localization of biochemical atherogenic. Finally, it’s interesting roles WSS SKB more complex where he was promoted or prevented by different biochemical atherosclerosis. We present a summary of the different pathways by which the WSS affect coronary artery atherosclerosis and compare mechanotransduction and biotransport different mechanisms.

Development of volatile organic compounds and their glycosylated precursors in tamarillo (Solanum betaceum Cav.) During fruit ripening: A prediction of biochemical pathways

key metabolites and pathways flavor-regulation in tamarillo investigated to explore the development of a free and glycosylation of volatile organic compounds (VOCs) during fruit ripening. The concentration of VOC-free and bound was determined by analysis by gas chromatography-mass spectrometry. Changes in physical parameters, the concentration of flavor precursors and key endogenous enzyme activity was also monitored.

A total of 22 VOC-free identified with C6 alcohols and esters into the main compound. Of the 83 VOCs detected glycosylation, phenols and terpenoids are the dominant component. The total concentration of VOCs is bound to increase up to four times during the ripening of fruit. Lipoxygenase pathway is confirmed as an important biosynthetic mechanism for the generation of VOC free and glycosylation during maturation tamarillo. This biosynthetic pathway is highly correlated with the activity of key enzymes and content of the substrate, especially of linolenic acid (p <0.05 or p <0.01).

Phenotypic, genotypic and biochemical changes during the selection of pyrethroid resistance in Anopheles gambiae mosquitoes

Directional Selection for insecticide resistance due to the indiscriminate use of insecticides in public health and agriculture system favors increased frequency of insecticide-resistant alleles in natural populations. Similarly, the removal of the selection pressure generally leads to rot in the resistance. recent investigations on the emergence of insecticide resistance in mosquitoes largely rely on field surveys resistance in vector populations that typically have a complex history of exposure to a variety of public health insecticides and pest control agricultural in nature, and thus the effects of certain insecticides on resistance levels level of emergency or resistance to decay unknown.

This study examined the phenotypic, genotypic, and biochemical changes that occur during the selection process for pyrethroid resistance in Anopheles gambiae, the most important vector of malaria in Africa. In parallel, we also examined the changes in the population hold when there is no selection pressure is applied.

Through repeated deltamethrin selection in adult mosquitoes from field populations collected in western Kenya for 12 generations, we obtain three independent and highly pyrethroid resistant An. gambiae populations. Three vulnerable populations from the same parent population is generated by removing the selection pressure.

Second row mosquito populations differ significantly in monooxygenases and beta-esterase activity, but not in Vgsc frequency of gene mutations, suggesting a metabolic detoxification mechanisms play a major role in generating resistance moderate intensity or high intensity resistance. Pre-exposure synergist piperonyl butoxide restored susceptibility to insecticides among highly resistant mosquitoes, confirming the role of monooxygenases in pyrethroid resistance.

The level of damage resistance to be fully susceptible of moderate intensity resistance took 15 generations, to support at least 2-year interval is required when using the rotation of insecticides with different modes of action to be considered for resistance management.

Biochemical parameters in Cognitive Function

cognitive impairment is a common disease. Many studies tried to elucidate the mechanisms of this dysfunction establishment, including the correlation between cognitive function and biochemical parameters. The scientists are looking for substances that will be an indicator of cognitive function and that can be determined in the cerebrospinal fluid or blood from subjects. Until now, they have isolated several such substances; However, research on the specificity of their validity and the possibility of their use in diagnostic and prognostic assessment is still ongoing.

However, there are only a few reports in the literature systematize the existing knowledge about this, and they are mostly associated with Alzheimer’s disease, not cognition in general, or refer only to certain groups of substances. This article discusses the most important biochemical exponent of cognitive function.

GALNT4 Antibody

DF13031-100ul 100ul
EUR 280

GALNT4 Antibody

DF13031-200ul 200ul
EUR 350

anti- GALNT4 antibody

FNab03324 100µg
EUR 658.5
Description: Antibody raised against GALNT4

GALNT4 siRNA

20-abx917540
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

GALNT4 siRNA

20-abx917541
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

Polypeptide N-Acetylgalactosaminyltransferase 4 (GALNT4) Antibody

abx233324-100ug 100 ug
EUR 610.8

Polypeptide N-Acetylgalactosaminyltransferase 4 (GALNT4) Antibody

20-abx116519
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Polypeptide N-Acetylgalactosaminyltransferase 4 (GALNT4) Antibody

abx025629-400ul 400 ul
EUR 627.6

Polypeptide N-Acetylgalactosaminyltransferase 4 (GALNT4) Antibody

abx025629-80l 80 µl
EUR 343.2

Polypeptide N-Acetylgalactosaminyltransferase 4 (GALNT4) Antibody

abx036817-100ug 100 ug
EUR 469.2

Polypeptide N-Acetylgalactosaminyltransferase 4 (GALNT4) Antibody

abx122500-100ug 100 ug
EUR 469.2

Polypeptide N-Acetylgalactosaminyltransferase 4 (GALNT4) Antibody

20-abx003143
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

GALNT4 Rabbit pAb

A4243-100ul 100 ul
EUR 369.6

GALNT4 Rabbit pAb

A4243-200ul 200 ul
EUR 550.8

GALNT4 Rabbit pAb

A4243-20ul 20 ul Ask for price

GALNT4 Rabbit pAb

A4243-50ul 50 ul Ask for price

GALNT4 cloning plasmid

CSB-CL836662HU-10ug 10ug
EUR 451.2
Description: A cloning plasmid for the GALNT4 gene.

GALNT4 Blocking Peptide

33R-1400 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GALNT4 antibody, catalog no. 70R-7245

GALNT4 Blocking Peptide

33R-9559 100 ug
EUR 216
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GALNT4 antibody, catalog no. 70R-7248

GALNT4 Blocking Peptide

DF13031-BP 1mg
EUR 234

GALNT4 ELISA KIT|Human

EF009763 96 Tests
EUR 826.8

Mouse Galnt4 ELISA KIT

ELI-27156m 96 Tests
EUR 1038

Human GALNT4 ELISA KIT

ELI-30796h 96 Tests
EUR 988.8

Human GALNT4 shRNA Plasmid

20-abx955721
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

Mouse GALNT4 shRNA Plasmid

20-abx970459
  • EUR 961.20
  • EUR 1345.20
  • 150 µg
  • 300 µg

GALNT4 Recombinant Protein (Rat)

RP202175 100 ug Ask for price

GALNT4 Recombinant Protein (Human)

RP012883 100 ug Ask for price

GALNT4 Recombinant Protein (Mouse)

RP135836 100 ug Ask for price

Galnt4 ORF Vector (Rat) (pORF)

ORF067393 1.0 ug DNA
EUR 607.2

GALNT4 (N-term) Rabbit pAb

E2611166 100ul
EUR 225
Description: Available in various conjugation types.

GALNT4 ORF Vector (Human) (pORF)

ORF004295 1.0 ug DNA
EUR 114

Galnt4 ORF Vector (Mouse) (pORF)

ORF045280 1.0 ug DNA
EUR 607.2

Human GALNT4 Protein Lysate 20ug

IHUGALNT4PLLY20UG each
EUR 213
Description: Human GALNT4 Protein Lysate 20ug

Galnt4 sgRNA CRISPR Lentivector set (Rat)

K7515601 3 x 1.0 ug
EUR 406.8

Galnt4 3'UTR GFP Stable Cell Line

TU254930 1.0 ml Ask for price

Galnt4 3'UTR GFP Stable Cell Line

TU156887 1.0 ml Ask for price

GALNT4 3'UTR GFP Stable Cell Line

TU058523 1.0 ml
EUR 2799.6

GALNT4 sgRNA CRISPR Lentivector set (Human)

K0835401 3 x 1.0 ug
EUR 406.8

Galnt4 sgRNA CRISPR Lentivector set (Mouse)

K3418201 3 x 1.0 ug
EUR 406.8

GALNT4 Protein Vector (Rat) (pPM-C-HA)

PV269572 500 ng
EUR 723.6

GALNT4 Protein Vector (Rat) (pPB-C-His)

PV269570 500 ng
EUR 723.6

GALNT4 Protein Vector (Rat) (pPB-N-His)

PV269571 500 ng
EUR 723.6

GALNT4 Protein Vector (Rat) (pPM-C-His)

PV269573 500 ng
EUR 723.6

GALNT4 Protein Vector (Human) (pPM-C-HA)

PV017179 500 ng
EUR 394.8

GALNT4 Protein Vector (Mouse) (pPM-C-HA)

PV181120 500 ng
EUR 723.6

GALNT4 Protein Vector (Human) (pPB-C-His)

PV017177 500 ng
EUR 394.8

GALNT4 Protein Vector (Human) (pPB-N-His)

PV017178 500 ng
EUR 394.8

GALNT4 Protein Vector (Human) (pPM-C-His)

PV017180 500 ng
EUR 394.8

GALNT4 Protein Vector (Mouse) (pPB-C-His)

PV181118 500 ng
EUR 723.6

GALNT4 Protein Vector (Mouse) (pPB-N-His)

PV181119 500 ng
EUR 723.6

GALNT4 Protein Vector (Mouse) (pPM-C-His)

PV181121 500 ng
EUR 723.6

GALNT4 3'UTR Luciferase Stable Cell Line

TU008523 1.0 ml
EUR 2799.6

Galnt4 3'UTR Luciferase Stable Cell Line

TU106887 1.0 ml Ask for price

Galnt4 3'UTR Luciferase Stable Cell Line

TU204930 1.0 ml Ask for price

Galnt4 sgRNA CRISPR Lentivector (Rat) (Target 1)

K7515602 1.0 ug DNA
EUR 184.8

Galnt4 sgRNA CRISPR Lentivector (Rat) (Target 2)

K7515603 1.0 ug DNA
EUR 184.8

Galnt4 sgRNA CRISPR Lentivector (Rat) (Target 3)

K7515604 1.0 ug DNA
EUR 184.8

GALNT4 sgRNA CRISPR Lentivector (Human) (Target 1)

K0835402 1.0 ug DNA
EUR 184.8

GALNT4 sgRNA CRISPR Lentivector (Human) (Target 2)

K0835403 1.0 ug DNA
EUR 184.8

GALNT4 sgRNA CRISPR Lentivector (Human) (Target 3)

K0835404 1.0 ug DNA
EUR 184.8

Galnt4 sgRNA CRISPR Lentivector (Mouse) (Target 1)

K3418202 1.0 ug DNA
EUR 184.8

Galnt4 sgRNA CRISPR Lentivector (Mouse) (Target 2)

K3418203 1.0 ug DNA
EUR 184.8

Galnt4 sgRNA CRISPR Lentivector (Mouse) (Target 3)

K3418204 1.0 ug DNA
EUR 184.8

GALNT4 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

LV638647 1.0 ug DNA
EUR 818.4

GALNT4 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC)

LV638651 1.0 ug DNA
EUR 818.4

GALNT4 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a)

LV638652 1.0 ug DNA
EUR 818.4

GALNT10 Antibody

24939-100ul 100ul
EUR 468

GALNT10 Antibody

24940-100ul 100ul
EUR 468

GALNT14 Antibody

40030-100ul 100ul
EUR 468

Galnt11 antibody

70R-8825 50 ug
EUR 560.4
Description: Affinity purified rabbit polyclonal Galnt11 antibody

GALNT10 Antibody

5279-002mg 0.02 mg
EUR 206.18
Description: GALNT10 Antibody: Protein glycosylation is an important biological process that is carried out by a large family of glycosyltransferases that catalyze the synthesis of oligosaccharides and glycoconjugates. Polypeptide GalNAc transferases initiate the synthesis of mucin-type oligosaccharides by transferring GalNAc from UDP-GalNAc to the hydroxyl group of either a serine or threonine residue on the polypeptide acceptor. Polypeptide galactoaminyltransferase 10 (GALNT10) belongs to the polypeptide N-acetylgalactosaminyl-transferase (pp-GalNAc-T) protein family. Following expression in insect cells, recombinant GALNT10 showed significant GalNAcT activity toward mucin-derived peptides, and it utilized both non-glycosylated and glycosylated peptide substrates. GALNT10 mRNA is highly expressed in several distinct hypothalamic, thalamic, and amygdaloid nuclei in mouse brain. At least four isoforms of GALNT10 are known to exist.

GALNT10 Antibody

5279-01mg 0.1 mg
EUR 523.7
Description: GALNT10 Antibody: Protein glycosylation is an important biological process that is carried out by a large family of glycosyltransferases that catalyze the synthesis of oligosaccharides and glycoconjugates. Polypeptide GalNAc transferases initiate the synthesis of mucin-type oligosaccharides by transferring GalNAc from UDP-GalNAc to the hydroxyl group of either a serine or threonine residue on the polypeptide acceptor. Polypeptide galactoaminyltransferase 10 (GALNT10) belongs to the polypeptide N-acetylgalactosaminyl-transferase (pp-GalNAc-T) protein family. Following expression in insect cells, recombinant GALNT10 showed significant GalNAcT activity toward mucin-derived peptides, and it utilized both non-glycosylated and glycosylated peptide substrates. GALNT10 mRNA is highly expressed in several distinct hypothalamic, thalamic, and amygdaloid nuclei in mouse brain. At least four isoforms of GALNT10 are known to exist.

GALNT10 Antibody

5281-002mg 0.02 mg
EUR 206.18
Description: GALNT10 Antibody: Protein glycosylation is an important biological process that is carried out by a large family of glycosyltransferases that catalyze the synthesis of oligosaccharides and glycoconjugates. Polypeptide GalNAc transferases initiate the synthesis of mucin-type oligosaccharides by transferring GalNAc from UDP-GalNAc to the hydroxyl group of either a serine or threonine residue on the polypeptide acceptor. Polypeptide galactoaminyltransferase 10 (GALNT10) belongs to the polypeptide N-acetylgalactosaminyl-transferase (pp-GalNAc-T) protein family. Following expression in insect cells, recombinant GALNT10 showed significant GalNAcT activity toward mucin-derived peptides, and it utilized both non-glycosylated and glycosylated peptide substrates. GALNT10 mRNA is highly expressed in several distinct hypothalamic, thalamic, and amygdaloid nuclei in mouse brain. At least four isoforms of GALNT10 are known to exist.

GALNT10 Antibody

5281-01mg 0.1 mg
EUR 523.7
Description: GALNT10 Antibody: Protein glycosylation is an important biological process that is carried out by a large family of glycosyltransferases that catalyze the synthesis of oligosaccharides and glycoconjugates. Polypeptide GalNAc transferases initiate the synthesis of mucin-type oligosaccharides by transferring GalNAc from UDP-GalNAc to the hydroxyl group of either a serine or threonine residue on the polypeptide acceptor. Polypeptide galactoaminyltransferase 10 (GALNT10) belongs to the polypeptide N-acetylgalactosaminyl-transferase (pp-GalNAc-T) protein family. Following expression in insect cells, recombinant GALNT10 showed significant GalNAcT activity toward mucin-derived peptides, and it utilized both non-glycosylated and glycosylated peptide substrates. GALNT10 mRNA is highly expressed in several distinct hypothalamic, thalamic, and amygdaloid nuclei in mouse brain. At least four isoforms of GALNT10 are known to exist.

GALNT14 antibody

70R-17413 50 ul
EUR 522
Description: Rabbit polyclonal GALNT14 antibody

GALNT14 antibody

70R-7437 50 ug
EUR 560.4
Description: Rabbit polyclonal GALNT14 antibody

GALNT13 antibody

70R-7449 50 ug
EUR 560.4
Description: Rabbit polyclonal GALNT13 antibody raised against the N terminal Of Galnt13

GALNT10 antibody

70R-5370 50 ug
EUR 560.4
Description: Rabbit polyclonal GALNT10 antibody raised against the N terminal Of Galnt10

GALNT12 Antibody

47372-100ul 100ul
EUR 302.4

GALNT14 Antibody

1-CSB-PA009208GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against GALNT14. Recognizes GALNT14 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

GALNT15 Antibody

1-CSB-PA009218GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against GALNT15. Recognizes GALNT15 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

GALNT12 Antibody

1-CSB-PA814224LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GALNT12. Recognizes GALNT12 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

GALNT15 Antibody

1-CSB-PA822698LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GALNT15. Recognizes GALNT15 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

GALNT14 Antibody

1-CSB-PA836212LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GALNT14. Recognizes GALNT14 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

GALNT11 Antibody

1-CSB-PA847687LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GALNT11. Recognizes GALNT11 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200

GALNT16 Antibody

1-CSB-PA850796LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GALNT16. Recognizes GALNT16 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:1000-1:5000

GALNT14 Antibody

DF13030 100ul
EUR 280
Description: Human,Mouse,Rat

GALNT12 Antibody

E047372 100μg/100μl
EUR 255
Description: Available in various conjugation types.

GALNT10 Antibody

E314623 200ul
EUR 275
Description: Available in various conjugation types.

GALNT18  Antibody

E40PV1566 50ul
EUR 395
Description: Available in various conjugation types.

GALNT12 Antibody

E306898 200ul
EUR 275
Description: Available in various conjugation types.

GALNT14 Antibody

E306929 100ug/200ul
EUR 275
Description: Available in various conjugation types.

GALNT14 Antibody

E306929b 200ul
EUR 275
Description: Available in various conjugation types.

GALNT13 Antibody

E310792 200ul
EUR 275
Description: Available in various conjugation types.

GALNT14 Antibody

E94973 100μg
EUR 255
Description: Available in various conjugation types.

GALNT14 Antibody

DF13030-100ul 100ul
EUR 280

GALNT14 Antibody

DF13030-200ul 200ul
EUR 350

GALNT1 Antibody

abx145974-100ug 100 ug
EUR 469.2

GALNT7 antibody

23130-100ul 100ul
EUR 468

GALNT2 antibody

22999-100ul 100ul
EUR 468

GALNT3 antibody

39032-100ul 100ul
EUR 302.4

GALNT9 Antibody

39419-100ul 100ul
EUR 468

GALNT6 Antibody

40029-100ul 100ul
EUR 468

Galnt3 antibody

70R-8653 50 ug
EUR 560.4
Description: Affinity purified rabbit polyclonal Galnt3 antibody

GALNT6 antibody

70R-1908 100 ug
EUR 452.4
Description: Rabbit polyclonal GALNT6 antibody raised against the N terminal of GALNT6

GALNT2 antibody

70R-12773 100 ul
EUR 548.4
Description: Affinity purified Rabbit polyclonal GALNT2 antibody

GALNT7 antibody

70R-12957 100 ul
EUR 548.4
Description: Affinity purified Rabbit polyclonal GALNT7 antibody

GALNT7 antibody

70R-17415 50 ul
EUR 522
Description: Rabbit polyclonal GALNT7 antibody

GALNT5 antibody

70R-7239 50 ug
EUR 560.4
Description: Rabbit polyclonal GALNT5 antibody

GALNT6 antibody

70R-7465 50 ug
EUR 560.4
Description: Rabbit polyclonal GALNT6 antibody

GALNT7 Antibody

1-CSB-PA009214GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against GALNT7. Recognizes GALNT7 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

GALNT9 Antibody

1-CSB-PA862072LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GALNT9. Recognizes GALNT9 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:500-1:5000

GALNT2 Antibody

1-CSB-PA605995ESR1HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against GALNT2. Recognizes GALNT2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

GALNT2 Antibody

1-CSB-PA605995ESR2HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against GALNT2. Recognizes GALNT2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

GALNT3 Antibody

1-CSB-PA613501ESR1HU
  • EUR 266.40
  • EUR 402.00
  • 100ul
  • 50ul
Description: A polyclonal antibody against GALNT3. Recognizes GALNT3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

GALNT7 Antibody

1-CSB-PA773016LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GALNT7. Recognizes GALNT7 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

GALNT2 Antibody

DF14912 100ul
EUR 280
Description: Human,Mouse

GALNT1 Antibody

DF15017 100ul
EUR 280
Description: Human,Mouse,Rat

GALNT7 Antibody

DF15255 100ul
EUR 280
Description: Human,Mouse,Rat

GALNT7 Antibody

E305002 100ug/200ul
EUR 275
Description: Available in various conjugation types.

GALNT9 Antibody

E305028 100ug/200ul
EUR 275
Description: Available in various conjugation types.

GALNT9 Antibody

E313444 100ug/200ul
EUR 295
Description: Available in various conjugation types.

GALNT3 Antibody

E314038 100ug/200ul
EUR 295
Description: Available in various conjugation types.

GALNT7 Antibody

E314460 100ug/200ul
EUR 295
Description: Available in various conjugation types.

GALNT6 Antibody

E306900 100ug/200ul
EUR 275
Description: Available in various conjugation types.

GALNT1 Antibody

E309559 200ul
EUR 275
Description: Available in various conjugation types.

GALNT2 Antibody

E309560 200ul
EUR 275
Description: Available in various conjugation types.

GALNT3 Antibody

E310793 200ul
EUR 275
Description: Available in various conjugation types.

GALNT3 Antibody

E96596 100ul
EUR 255
Description: Available in various conjugation types.

GALNT2 Antibody

DF14912-100ul 100ul
EUR 280

GALNT2 Antibody

DF14912-200ul 200ul
EUR 350

GALNT1 Antibody

DF15017-100ul 100ul
EUR 280

GALNT1 Antibody

DF15017-200ul 200ul
EUR 350

GALNT7 Antibody

DF15255-100ul 100ul
EUR 280

GALNT7 Antibody

DF15255-200ul 200ul
EUR 350

GALNT11 Antibody (HRP)

20-abx313734
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

GALNT12 Antibody (HRP)

20-abx308604
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

GALNT16 Antibody (HRP)

20-abx310083
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

anti- GALNT14 antibody

FNab03323 100µg
EUR 658.5
Description: Antibody raised against GALNT14

GALNT11 Antibody (FITC)

20-abx313735
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

GALNT12 Antibody (FITC)

20-abx308605
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

GALNT16 Antibody (FITC)

20-abx310084
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

anti- GALNT7 antibody

FNab03325 100µg
EUR 658.5
Description: Antibody raised against GALNT7

anti- GALNT9 antibody

FNab03326 100µg
EUR 658.5
Description: Antibody raised against GALNT9

Galnt4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)

K7515605 3 x 1.0 ug
EUR 451.2

GALNT11 Antibody (Biotin)

20-abx313736
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

GALNT12 Antibody (Biotin)

20-abx308606
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

GALNT16 Antibody (Biotin)

20-abx310085
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

GALNT4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

K0835405 3 x 1.0 ug
EUR 451.2

Galnt4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)

K3418205 3 x 1.0 ug
EUR 451.2

Human Polypeptide N-Acetylgalactosaminyltransferase 4 (GALNT4) ELISA Kit

abx387484-96tests 96 tests
EUR 1093.2

GALNT12 Antibody, HRP conjugated

1-CSB-PA814224LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GALNT12. Recognizes GALNT12 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

GALNT15 Antibody, HRP conjugated

1-CSB-PA822698LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GALNT15. Recognizes GALNT15 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

GALNT14 Antibody, HRP conjugated

1-CSB-PA836212LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GALNT14. Recognizes GALNT14 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

GALNT11 Antibody, HRP conjugated

1-CSB-PA847687LB01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against GALNT11. Recognizes GALNT11 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA

Leave a Reply

Your email address will not be published.